The Cooper Companies, Inc. $COO Shares Sold by AlphaQuest LLC

Key Points

• AlphaQuest LLC has significantly reduced its stake in The Cooper Companies, Inc. by 89.5%, now holding only 1,463 shares after selling 12,475 during the first quarter.
• Several analysts have downgraded their price targets for Cooper Companies, with Robert W. Baird and Stifel Nicolaus both lowering theirs to $85.00, indicating a more cautious outlook.
• The medical device company reported a quarterly EPS of $1.10, exceeding estimates, and set guidance for Q4 2025 EPS between 1.100-1.140.

AlphaQuest LLC cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 89.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,463 shares of the medical device company's stock after selling 12,475 shares during the quarter. AlphaQuest LLC's holdings in Cooper Companies were worth $123,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Goldman Sachs Group Inc. boosted its holdings in Cooper Companies by 17.0% in the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock valued at $399,340,000 after acquiring an additional 686,751 shares in the last quarter. Nuveen LLC purchased a new position in shares of Cooper Companies in the 1st quarter worth about $55,367,000. Price T Rowe Associates Inc. MD raised its position in shares of Cooper Companies by 12.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company's stock worth $333,595,000 after purchasing an additional 425,400 shares during the last quarter. SG Americas Securities LLC raised its position in Cooper Companies by 8,337.0% in the 1st quarter. SG Americas Securities LLC now owns 369,542 shares of the medical device company's stock worth $31,171,000 after buying an additional 365,162 shares during the last quarter. Finally, Russell Investments Group Ltd. raised its position in Cooper Companies by 76.1% in the 1st quarter. Russell Investments Group Ltd. now owns 703,690 shares of the medical device company's stock worth $59,348,000 after buying an additional 304,000 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Trading Up 2.8%

Shares of NASDAQ:COO traded up $1.81 during midday trading on Wednesday, reaching $67.14. 3,823,719 shares of the company's stock were exchanged, compared to its average volume of 2,658,597. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.23. The stock has a market cap of $13.35 billion, a price-to-earnings ratio of 33.07, a P/E/G ratio of 1.63 and a beta of 0.97. The firm's 50 day simple moving average is $72.09 and its two-hundred day simple moving average is $76.99. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The company's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In related news, COO Daniel G. Mcbride purchased 3,000 shares of the firm's stock in a transaction that occurred on Tuesday, September 2nd. The stock was purchased at an average cost of $65.04 per share, with a total value of $195,120.00. Following the completion of the acquisition, the chief operating officer directly owned 63,120 shares in the company, valued at $4,105,324.80. This trade represents a 4.99% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Brian G. Andrews purchased 1,525 shares of the company's stock in a transaction dated Tuesday, September 2nd. The stock was purchased at an average price of $65.68 per share, with a total value of $100,162.00. Following the transaction, the executive vice president owned 22,191 shares of the company's stock, valued at approximately $1,457,504.88. This represents a 7.38% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.98% of the stock is owned by company insiders.

Analyst Ratings Changes

COO has been the subject of a number of recent analyst reports. Stifel Nicolaus decreased their target price on Cooper Companies from $90.00 to $85.00 and set a "buy" rating for the company in a research report on Thursday, August 28th. Needham & Company LLC reaffirmed a "buy" rating and set a $94.00 price objective on shares of Cooper Companies in a report on Thursday, August 28th. JPMorgan Chase & Co. decreased their price target on Cooper Companies from $76.00 to $66.00 and set a "neutral" rating on the stock in a report on Thursday, August 28th. Robert W. Baird decreased their price target on Cooper Companies from $97.00 to $85.00 and set an "outperform" rating on the stock in a report on Thursday, August 28th. Finally, Mizuho cut their price objective on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $86.64.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.